Sep 18, 2025 8:16 pm
- Retro Biosciences is a longevity startup backed by OpenAI's CEO, Sam Altman.
- Retro's said its first human clinical trial is set to launch by the end of 2025.
- It's for a pill designed to clear out "gunk" in the brain and reverse Alzheimer's.